Herbal medicinal product

What is Angocin and when is it used?

Angocin is a medicine containing nasturtium herb powder and horseradish root powder. Angocin is applied:

• Traditionally used to improve symptoms of acute inflammation of the bronchi and paranasal sinuses;
• Traditionally used in female adults with symptoms of urinary tract infections.

What should be considered?

For use in symptoms of acute inflammation of the respiratory tract: For symptoms that last longer than a week or if shortness of breath occurs, fever such as A doctor should also be consulted if there is purulent or bloody sputum.

For use in symptoms of urinary tract infections: A doctor should be consulted if there is blood in the urine, fever or if the symptoms persist for more than 5 days.

Urinary tract problems in children and adolescents under the age of 18, as well as male adults and pregnant women, are generally considered to be complicated, require medical evaluation and must not be treated with Angocin (see also "When should Angocin not be taken or should only be taken with caution?").

The active ingredient nasturtium herb powder contains vitamin K. If Angocin is taken at the same time as anticoagulant drugs (so-called vitamin K antagonists), it cannot be ruled out that the effect of these anticoagulant drugs will be impaired. When taking the anticoagulant drugs mentioned (e.g. Marcoumar or Sintrom or other products with these active ingredients), it is therefore recommended to check the Quick value or INR value closely or have it checked and to consult the doctor or nurse in charge. to consult the treating doctor.

In children aged 6 to 12 years with symptoms of acute inflammation of the airways, Angocin should only be used after consulting a doctor.

The use of Angocin in children under 6 years of age has not been adequately studied. It should therefore not be used in this age group.

When should Angocin not be taken or only with caution?

Angocin should not be taken,

• if you are hypersensitive to nasturtium herb, horseradish root or any of the excipients of this medicine (see «What does Angocin contain?»),
• if you suffer from acute gastric or intestinal ulcers,
• if you suffer from acute kidney inflammation,
• if you are pregnant.

Urinary tract problems in children and adolescents under the age of 18 as well as male adults and pregnant women apply in principle as complicated, require a medical examination and must not be treated with Angocin (see under «What should be considered?»)

Tell your doctor, pharmacist or druggist if you

• suffer from other diseases,
• have allergies or

take other medicines (including those you bought yourself!)!

Can Angocin be taken while pregnant or breastfeeding?

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby , ask your doctor, pharmacist or druggist for advice before taking this medicine.

For fundamental medical reasons, no treatment should be carried out during pregnancy (see "What should be considered?" and "When should Angocin not be taken or should only be taken with caution?").

Angocin does not yet have adequate data on its use during pregnancy. It is not known whether the active substances in Angocin are excreted in human milk. The drug should therefore not be used during pregnancy and breast-feeding.

How do you use Angocin?

Complaints with acute inflammation of the respiratory tract

If prescribed by a doctor not otherwise prescribed:

Adults and adolescents over 12 years

4-5 film-coated tablets 3-5 times a day (standard dose: 4 film-coated tablets 3 times a day)

Children from 6 to 12 years only on the doctor's orders

2-4 film-coated tablets 3-4 times a day (standard dose: 3 film-coated tablets 3 times a day)

Complaints with urinary tract infections

Female adults over the age of 18 (pregnancy must be ruled out)

3-5 times 4-5 film-coated tablets daily (standard dose: 4 film-coated tablets 3 times a day).

Please take the film-coated tablets whole with sufficient liquid after meals.

Angocin should not be taken for more than two weeks.

Follow the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can Angocin have?

Like all medicines, this medicine can have side effects. The following side effects have been observed with Angocin:

• Common: Stomach and intestinal problems such as nausea, upper abdominal pressure, diarrhea, flatulence or heartburn.
  In this case, we recommend reducing the dose. If the symptoms persist, you should stop taking the medicine and talk to your doctor.
• Uncommon: Allergic reactions affecting the whole body and hypersensitivity reactions of the skin ( e.g. reddening of the skin with a feeling of heat, skin rash and/or itching).

In this case, you should stop taking the medicine immediately and consult a doctor immediately.

If you get any side effects, talk to your doctor, pharmacist or druggist. This applies in particular to side effects that are not listed in

indicated in this leaflet.

What else needs to be considered?

The medicinal product may only be used up to the date marked «EXP» on the container.

Storage instructions

Do not store above 30 °C and keep out of the reach of children.

Further information

Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.

What does Angocin contain?

Active ingredients

1 film-coated tablet contains: Nasturtium herb powder 200 mg, horseradish root powder 80 mg < /p>

Excipients

Cellulose, hypromellose, potato starch, macrogol, sodium carboxymethyl starch, colloidal silica, stearic acid, talc, coloring (iron oxides and hydroxides E 172, titanium dioxide E 171)

Approval number

66092 (Swissmedic)

Where can you get Angocin? What packs are available?

In pharmacies and drugstores, without a doctor's prescription.

Packs of 50, 100 and 200 film-coated tablets.

Authorization holder

Max Zeller Söhne AG, 8590 Romanshorn

This leaflet was last checked by the Medicines Agency (Swissmedic) in November 2017.